BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22116775)

  • 1. High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer.
    Badovinac Črnjević T; Spagnoli G; Juretić A; Jakić-Razumović J; Podolski P; Šarić N
    Med Oncol; 2012 Sep; 29(3):1586-91. PubMed ID: 22116775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancers.
    Raghavendra A; Kalita-de Croft P; Vargas AC; Smart CE; Simpson PT; Saunus JM; Lakhani SR
    Histopathology; 2018 Jul; 73(1):68-80. PubMed ID: 29465777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of cancer testis antigens and topoisomerase 2-alpha in triple negative breast carcinomas.
    Mrklić I; Spagnoli GC; Juretić A; Pogorelić Z; Tomić S
    Acta Histochem; 2014 Jun; 116(5):740-6. PubMed ID: 24560456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible predictive role of cancer/testis antigens in breast ductal carcinoma
    Roguljic A; Spagnoli G; Juretic A; Sarcevic B; Banovic M; Beketic Oreskovic L
    Oncol Lett; 2018 Dec; 16(6):7245-7255. PubMed ID: 30546463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: a retrospective clinical study.
    Lian Y; Sang M; Ding C; Zhou X; Fan X; Xu Y; Lü W; Shan B
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):519-27. PubMed ID: 22198676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-testis antigen expression in triple-negative breast cancer.
    Curigliano G; Viale G; Ghioni M; Jungbluth AA; Bagnardi V; Spagnoli GC; Neville AM; Nolè F; Rotmensz N; Goldhirsch A
    Ann Oncol; 2011 Jan; 22(1):98-103. PubMed ID: 20610479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study.
    Matković B; Juretić A; Spagnoli GC; Separović V; Gamulin M; Separović R; Sarić N; Basić-Koretić M; Novosel I; Kruslin B
    Croat Med J; 2011 Apr; 52(2):171-7. PubMed ID: 21495200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
    Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
    Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
    Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
    Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas.
    Mengus C; Schultz-Thater E; Coulot J; Kastelan Z; Goluza E; Coric M; Spagnoli GC; Hudolin T
    Int J Cancer; 2013 May; 132(10):2459-63. PubMed ID: 23125074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?
    Tessari A; Pilla L; Silvia D; Duca M; Paolini B; Carcangiu ML; Mariani L; de Braud FG; Cresta S
    Breast; 2018 Dec; 42():68-73. PubMed ID: 30189381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tumor-associated antigens in breast cancer subtypes.
    Curigliano G; Bagnardi V; Ghioni M; Louahed J; Brichard V; Lehmann FF; Marra A; Trapani D; Criscitiello C; Viale G
    Breast; 2020 Feb; 49():202-209. PubMed ID: 31869767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAGEA4 expression in bone and soft tissue tumors: its utility as a target for immunotherapy and diagnostic marker combined with NY-ESO-1.
    Iura K; Kohashi K; Ishii T; Maekawa A; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Matsumoto Y; Iwamoto Y; Oda Y
    Virchows Arch; 2017 Sep; 471(3):383-392. PubMed ID: 28744588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
    Laban S; Atanackovic D; Luetkens T; Knecht R; Busch CJ; Freytag M; Spagnoli G; Ritter G; Hoffmann TK; Knuth A; Sauter G; Wilczak W; Blessmann M; Borgmann K; Muenscher A; Clauditz TS
    Int J Cancer; 2014 Sep; 135(5):1142-52. PubMed ID: 24482145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sperm protein 17, MAGE-C1 and NY-ESO-1 in hepatocellular carcinoma: expression frequency and their correlation with clinical parameters.
    Xia QY; Liu S; Li FQ; Huang WB; Shi LN; Zhou XJ
    Int J Clin Exp Pathol; 2013; 6(8):1610-6. PubMed ID: 23923079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
    Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
    Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
    Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development.
    Gjerstorff MF; Kock K; Nielsen O; Ditzel HJ
    Hum Reprod; 2007 Apr; 22(4):953-60. PubMed ID: 17208940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.